Qiming Weekly | Qiming Venture Partners Portfolio Funding and Updates Vol. 07, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Registration is now officially open.
The so-called "building the next generation of information interaction experiences"
Where is the moat for large language model companies?
A pile of seeds sits before you — which ones will sprout fastest? Which will yield the most? Which will have the best quality? Traditional breeding requires months of careful observation in the field, taking at least three months of "looking, smelling, asking, and examining" to find answers. But at Shijiazhuang Biolid Biotechnology, it takes just 7 to 14 days. How is this possible? Welcome to **Dalton Venture Family company Biolid**, as we explore how Biolid spent eight years breaking foreign technology monopolies to successfully develop liquid-phase chip detection technology, dramatically shortening seed [text cuts off]
A pioneer in China's original medical device innovation.
"Different Money"
The project marks an unprecedented collaboration among four industry-leading companies, all united by a shared vision: equitable, shared autonomous mobility services should blanket every corner of cities and suburbs alike, accelerating the shift to greener transportation and giving residents easier access to work, healthcare, education, and leisure.
This round was oversubscribed twice, making it the largest market-driven financing in the Asia-Pacific innovative medical device sector in recent years.
A more aggressive signal.